Abstract
House dust mite allergies are important causes of allergic asthma and perennial allergic rhinitis. Therapeutic options for these disorders include environmental controls, antiallergic drugs and specific immunotherapy. Controlled clinical trials of dust mite immunotherapy for asthma and allergic rhinitis have generally demonstrated efficacy. Therapy with Dermatophagoides extracts that are standardized for allergenic potency are recommended. Caution should be exercised when treating young children or severe asthmatics because a high rate of systemic allergic reactions has been observed in these groups.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
